“Super Committee” on deficit reduction is considering cuts to reimbursements for medications

WASHINGTON – In a bipartisan effort to maintain the high quality of cancer care in the United States, U.S. Reps. Leonard Lance (R-NJ-7) and Bill Pascrell, Jr. (D-NJ-8) today rallied more than 60 Congress members to urge the Joint Committee on Deficit Reduction to not cut $3 billion from Medicare Part B reimbursements for medications that fight cancer and other serious diseases. 

Today, the two lawmakers submitted a letter, signed by 61 members of Congress, to U.S. Rep. Jeb Hensarling (R-TX) and U.S. Sen. Patty Murray (D-WA), co-chairs of the Joint Committee on Deficit Reduction.

“We thank the outstanding leadership of Congressmen Pascrell and Lance in rallying their bipartisan colleagues to support cancer care,” said Ted Okon, Executive Director of the Community Oncology Alliance. “Cancer care is in crisis as evidenced by clinic closings and drug shortages and simply cannot absorb any additional payment cuts.”

Click here to read the full text of the Lance-Pascrell letter.

###